The Risk of Developing Second Primary Malignancies in Cutaneous Melanoma Survivors

J Am Acad Dermatol. 2024 Dec 11:S0190-9622(24)03364-4. doi: 10.1016/j.jaad.2024.11.059. Online ahead of print.

¹ Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, PA.
² Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, PA; Department of Internal Medicine, Lankenau Medical Center, Wynnewood, PA.
³ Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, PA; Division of Hematologic Malignancies and Cellular Therapy, Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA, USA.
⁴ Department of Biostatistics, Thomas Jefferson University, Philadelphia, PA.
⁵ Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, PA. Electronic address: Neda.nikbakht@jefferson.edu.

No abstract available

Keywords: Surveillance; cutaneous melanoma; epidemiology end results (SEER); melanoma; second cancers; second primary malignancy (SPM).